Literature DB >> 25959519

[The low doses of radiation: Towards a new reading of the risk assessment].

Anne-Fleur Perez1, Clément Devic1, Catherine Colin1, Nicolas Foray2.   

Abstract

From Hiroshima bomb explosion data, the risk of radiation-induced cancer is significant from 100 mSv for a population considered as uniform and radioresistant. However, the recent radiobiological data bring some new elements that highlight some features that were not taken into account: the individual factor, the dose rate and the repeated dose effect. The objective evaluation of the cancer risk due to doses lower than 100 mSv is conditioned by high levels of measurability and statistical significance. However, it appears that methodological rigor is not systematically applied in all the papers. Furthermore, unclear communication in press often leads to some announcement effects, which does not improve the readability of the issue. This papers aims to better understand the complexity of the low-dose-specific phenomena as a whole, by confronting the recent biological data with epidemiological data.
Copyright © 2015 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; Faibles doses; Ionizing radiation; Low doses; Radiations ionisantes; Radiosensibilité; Radiosensitivity

Mesh:

Substances:

Year:  2015        PMID: 25959519     DOI: 10.1016/j.bulcan.2015.03.019

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  2 in total

1.  Task-based quantification of image quality using a model observer in abdominal CT: a multicentre study.

Authors:  Damien Racine; Nick Ryckx; Alexandre Ba; Fabio Becce; Anais Viry; Francis R Verdun; Sabine Schmidt
Journal:  Eur Radiol       Date:  2018-06-01       Impact factor: 5.315

2.  Breast Cancer Induced by X-Ray Mammography Screening? A Review Based on Recent Understanding of Low-Dose Radiobiology.

Authors:  Ernest K J Pauwels; Nicolas Foray; Michel H Bourguignon
Journal:  Med Princ Pract       Date:  2015-11-16       Impact factor: 1.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.